These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 31167658)

  • 1. MR-guidance in clinical reality: current treatment challenges and future perspectives.
    Corradini S; Alongi F; Andratschke N; Belka C; Boldrini L; Cellini F; Debus J; Guckenberger M; Hörner-Rieber J; Lagerwaard FJ; Mazzola R; Palacios MA; Philippens MEP; Raaijmakers CPJ; Terhaard CHJ; Valentini V; Niyazi M
    Radiat Oncol; 2019 Jun; 14(1):92. PubMed ID: 31167658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical physics challenges in clinical MR-guided radiotherapy.
    Kurz C; Buizza G; Landry G; Kamp F; Rabe M; Paganelli C; Baroni G; Reiner M; Keall PJ; van den Berg CAT; Riboldi M
    Radiat Oncol; 2020 May; 15(1):93. PubMed ID: 32370788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and longitudinal assessment of daily quality assurance for an MR-guided radiotherapy (MRgRT) linac.
    Mittauer KE; Dunkerley DAP; Yadav P; Bayouth JE
    J Appl Clin Med Phys; 2019 Nov; 20(11):27-36. PubMed ID: 31633882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience.
    Garcia Schüler HI; Pavic M; Mayinger M; Weitkamp N; Chamberlain M; Reiner C; Linsenmeier C; Balermpas P; Krayenbühl J; Guckenberger M; Baumgartl M; Wilke L; Tanadini-Lang S; Andratschke N
    Radiat Oncol; 2021 Nov; 16(1):217. PubMed ID: 34775998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
    Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
    Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
    Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
    Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in-silico assessment of the dosimetric benefits of MR-guided radiotherapy for esophageal cancer patients.
    Boekhoff M; Defize I; Borggreve A; van Hillegersberg R; Kotte A; Lagendijk J; van Lier A; Ruurda J; Takahashi N; Mook S; Meijer G
    Radiother Oncol; 2021 Sep; 162():76-84. PubMed ID: 34237345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR-guidance--a clinical study to evaluate a shuttle- based MR-linac connection to provide MR-guided radiotherapy.
    Bostel T; Nicolay NH; Grossmann JG; Mohr A; Delorme S; Echner G; Häring P; Debus J; Sterzing F
    Radiat Oncol; 2014 Jan; 9():12. PubMed ID: 24401489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial Intelligence in magnetic Resonance guided Radiotherapy: Medical and physical considerations on state of art and future perspectives.
    Cusumano D; Boldrini L; Dhont J; Fiorino C; Green O; Güngör G; Jornet N; Klüter S; Landry G; Mattiucci GC; Placidi L; Reynaert N; Ruggieri R; Tanadini-Lang S; Thorwarth D; Yadav P; Yang Y; Valentini V; Verellen D; Indovina L
    Phys Med; 2021 May; 85():175-191. PubMed ID: 34022660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment plan quality during online adaptive re-planning.
    van Timmeren JE; Chamberlain M; Krayenbuehl J; Wilke L; Ehrbar S; Bogowicz M; Hartley C; Zamburlini M; Andratschke N; Garcia Schüler H; Pavic M; Balermpas P; Ryu C; Guckenberger M; Tanadini-Lang S
    Radiat Oncol; 2020 Aug; 15(1):203. PubMed ID: 32825848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time motion-including dose estimation of simulated multi-leaf collimator-tracked magnetic resonance-guided radiotherapy.
    Persson E; Goodwin E; Eiben B; Wetscherek A; Nill S; Oelfke U
    Med Phys; 2024 Mar; 51(3):2221-2229. PubMed ID: 37898109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrafraction organ movement in adaptive MR-guided radiotherapy of abdominal lesions - dosimetric impact and how to detect its extent in advance.
    Buchele C; Renkamp CK; Regnery S; Behnisch R; Rippke C; Schlüter F; Hoegen-Saßmannshausen P; Debus J; Hörner-Rieber J; Alber M; Klüter S
    Radiat Oncol; 2024 Jun; 19(1):80. PubMed ID: 38918828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy.
    Nicosia L; Sicignano G; Rigo M; Figlia V; Cuccia F; De Simone A; Giaj-Levra N; Mazzola R; Naccarato S; Ricchetti F; Vitale C; Ruggieri R; Alongi F
    Acta Oncol; 2021 Feb; 60(2):215-221. PubMed ID: 32945701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI quality control for low-field MR-IGRT systems: Lessons learned.
    Michael Gach H; Curcuru AN; Wittland EJ; Maraghechi B; Cai B; Mutic S; Green OL
    J Appl Clin Med Phys; 2019 Oct; 20(10):53-66. PubMed ID: 31541542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Magnetic-resonance-guided radiotherapy : The beginning of a new era in radiation oncology?].
    Hoegen P; Spindeldreier CK; Buchele C; Rippke C; Regnery S; Weykamp F; Klüter S; Debus J; Hörner-Rieber J
    Radiologe; 2021 Jan; 61(1):13-20. PubMed ID: 33052442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Intensity Modulated Radiotherapy Treatment Plans Between 1.5T MR-Linac and Conventional Linac.
    Ding S; Li Y; Liu H; Li R; Wang B; Zhang J; Chen Y; Huang X
    Technol Cancer Res Treat; 2021; 20():1533033820985871. PubMed ID: 33472549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
    Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
    Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer.
    Cusumano D; Boldrini L; Menna S; Teodoli S; Placidi E; Chiloiro G; Placidi L; Greco F; Stimato G; Cellini F; Valentini V; Azario L; De Spirito M
    J Appl Clin Med Phys; 2019 Sep; 20(9):20-30. PubMed ID: 31444952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of MR-Linac in tumor radiotherapy: a systematic review.
    Liu X; Li Z; Yin Y
    Radiat Oncol; 2023 Mar; 18(1):52. PubMed ID: 36918884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.